WENCO-INTERNATIONAL
14.9.2022 05:01:37 CEST | Business Wire | Press release
Wenco International Mining Systems Ltd. ("Wenco") is pleased to expand its sales and support to customers in Northern Europe through its new partnership with Rotator Oy, a leading provider of mining equipment and solutions, based in Finland.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220913006133/en/
This new agreement extends Wenco’s reach with a capable value-added reseller, paving the way for customers in the region to further leverage Wenco’s open and interoperable approach to mining technology.
Wenco is a leading provider of technology solutions to the global mining industry with a comprehensive suite of digital solutions that boost productivity, decrease operating costs, extend equipment life, enhance safety, and give mining companies actionable insights into their operations. Mines realize these benefits through systems for fleet management, machine guidance, safety, and asset health — all grounded in an open systems philosophy that empowers them to freely integrate systems to support their unique business processes, data requirements, and reporting needs.
“We’re very positive about the establishment of this partnership with Rotator,” says Andrew Pyne, President and CEO of Wenco. “They have a very strong presence in the region and an excellent track record of sales and support for Hitachi Construction Machinery, our parent company. We’re looking forward to working closely with Rotator to deliver value through the application of our technologies to their customers in the region.”
Rotator CEO Janne Wartiovaara concurs with Pyne. “We are excited to add Wenco to our Mining offering and look forward to bring more valuable solutions to our customers,” says Janne Wartiovaara.
In addition to solutions for fleet operations, Rotator and Wenco are introducing innovative fatigue management solutions to the market with Wenco’s SmartCap, the only technology proven to eliminate safety incidents caused by fatigue. SmartCap uses EEG to measure operator fatigue, then notify users of reduced ability to resist sleep — before a fatigue-related incident occurs.
Wenco and Rotator formed this partnership due to their shared focus on delivering customer-centric solutions to the mining industry. Founded in 1954, Rotator is one of the most experienced and well-established machine import and after-sales service companies in Finland. Located in Pirkkala with satellite offices in Vantaa, Kuopio, Seinäjoki, Oulu, Rovaniemi, Sotkamo, and Lieto, Rotator is committed to providing reliable, efficient, and safe solutions to customers through Finland and Sweden.
The company’s rich history of support for customers made it a natural partner for Wenco in Northern Europe.
Rotator is now in discussions with mines across Finland and Sweden on how they can advance their digital transformation with Wenco’s solutions. To learn more, please contact Rotator Sales Manager Sami Laitila at sami.laitila@rotator.fi or +35840-8242-495. For all other inquiries into Wenco and its solutions, please contact Wenco Regional Manager Europe, Middle East, and Kazakhstan, Klaus Hansson at khansson@wencomine.com or +971-522-600-596.
About Wenco International Mining Systems
For over 30 years, Wenco International Mining Systems has worked with mining companies to extract unrealized value. In support of this mission, Wenco has developed an integrated suite of solutions to support the digital transformation of the mining industry. Fleet management, asset health, fatigue management, and other technologies join together in the spirit of open interoperability to raise mine productivity and efficiency, lower routine costs, and establish a safe and smooth mining operation.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220913006133/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press release
REACH study met its first primary endpoint, showing that Broncho‑Vaxom® (OM‑85) was associated with a 28-38% reduction in respiratory tract infection rates at 12 months and 29-41% reduction at 24 months, comparing post-treatment versus pre-treatment initiation.1 The reduction was observed regardless of the frequency of respiratory tract infections in the previous year (1-3, >3) and across age subgroups (1-5, 6-11, 12-17, 18-64, >64 years).1 By reflecting everyday clinical practice and capturing episodes that necessitated a visit to the doctor, these extensive data offer critical new evidence of the therapy’s long-term relevance for patients suffering from recurrent respiratory tract infections. Evaluating a vast cohort of more than 15,790 paediatric, adolescent, adult and elderly patients in China, Italy, and Belgium, REACH represents the largest and only multi-country real-world evidence study to date for Broncho-Vaxom®.1,2 The study cohort includes patients with different co-morbidit
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press release
In myelofibrosis (MF), INCA033989 delivered rapid and durable clinical benefits including meaningful spleen volume reductions, symptom improvement and anemia responses, both as a monotherapy and in combination with ruxolitinibIn essential thrombocythemia (ET), 87% of patients achieved a hematologic response, including 70% complete responses; responses were rapid (median ~2 weeks to a durable complete hematologic response) and durable (median response duration of 23 weeks)Across MF and ET, INCA033989 consistently reduced mutant CALR (mutCALR) variant allele frequency (VAF) in most evaluable patients, with reductions correlating with clinical responses and supporting its potential for disease modificationFirst-in-class mutCALR-targeted antibody shows potential to modify disease biology in both MF and ETINCA033989 demonstrated a favorable and manageable safety profile with no dose-limiting toxicities, with most patients with MF and ET continuing treatment Incyte (Nasdaq:INCY) today announ
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi®/Minjuvi®) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press release
- frontMIND study evaluating tafasitamab (Monjuvi®/Minjuvi®) in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL) selected for the prestigious Plenary Abstracts Session at EHA 2026 - Results showed tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) significantly prolonged progression-free survival (PFS), reducing risk of disease progression or death by 25% - Positive trends toward PFS benefit with Tafa-Len-R-CHOP were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypes - The frontMIND data support global regulatory applications for tafasitamab and lenalidomide in addition to R-CHOP for previously untreated DLBCL and HGBL Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified c
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 18:36:00 CEST | Press release
Venneman brings more than 30 years of digital transformation, AI, and enterprise technology experience as IQM prepares for its planned Nasdaq listing IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom